GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NeoPharm Co 092730.KQ · KRW

Consumer Staples · KOSDAQ · 🇰🇷 South Korea

Compare

23,350

-0.64%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩132.18bn

FY2016FY2025

Net income

₩27.82bn

FY2016FY2025

Free cash flow

₩26.99bn

FY2016FY2025

Shareholders' equity

₩195.36bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩132.18bn₩119.01bn₩97.10bn₩85.03bn₩87.93bn₩81.63bn₩83.24bn₩66.27bn₩53.63bn₩42.37bn
Gross profit₩86.40bn₩74.03bn₩65.39bn₩58.38bn₩62.39bn₩58.64bn₩60.10bn₩48.34bn₩40.14bn₩31.88bn
Research and development₩3.33bn₩3.41bn₩2.65bn₩2.85bn₩2.94bn₩2.80bn₩2.52bn₩2.58bn₩2.10bn₩2.18bn
Operating income₩28.77bn₩24.65bn₩25.29bn₩21.43bn₩22.42bn₩21.90bn₩22.71bn₩19.18bn₩14.08bn₩9.56bn
Net income₩27.82bn₩23.06bn₩23.21bn₩17.03bn₩17.71bn₩18.13bn₩19.25bn₩15.37bn₩11.56bn₩7.74bn
Diluted earnings per share1,778.811,474.612,968.152,177.202,264.942,318.342,456.842,150.331,566.061,094.42

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩217.81bn₩192.44bn₩177.46bn₩155.35bn₩143.41bn₩132.98bn₩122.74bn₩72.93bn₩56.69bn₩46.51bn
Cash and short-term investments———₩113.49bn₩105.05bn₩96.18bn₩85.52bn₩42.42bn₩31.43bn₩24.23bn
Total liabilities₩22.45bn₩15.56bn₩17.43bn₩13.14bn₩13.10bn₩15.26bn₩17.05bn₩13.64bn₩9.11bn₩7.94bn
Debt—₩629.4m₩1.07bn₩412.2m₩558.8m₩4.31bn₩4.66bn₩400.0m₩64.0m₩57.0m
Shareholders' equity₩195.36bn₩176.88bn₩160.03bn₩142.21bn₩130.30bn₩117.72bn₩105.69bn₩59.29bn₩47.58bn₩38.57bn
Shares outstanding16m16m8m8m8m8m8m7m7m7m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩28.41bn₩18.63bn₩23.26bn₩18.16bn₩21.68bn₩17.07bn₩19.22bn₩16.18bn₩10.65bn₩9.16bn
Capital spending−₩1.42bn−₩3.08bn−₩20.83bn−₩806.4m−₩320.1m−₩285.6m−₩5.90bn−₩1.94bn−₩884.7m−₩1.40bn
Free cash flow₩26.99bn₩15.55bn₩2.43bn₩17.35bn₩21.36bn₩16.79bn₩13.32bn₩14.24bn₩9.76bn₩7.75bn
Dividends paid−₩9.38bn−₩5.87bn−₩5.47bn−₩5.47bn−₩5.08bn−₩5.87bn−₩4.60bn−₩3.54bn−₩2.48bn−₩1.77bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩43.57bn₩36.22bn₩36.40bn₩32.20bn₩31.98bn₩31.61bn₩34.03bn₩26.15bn
Gross profit₩29.57bn₩24.15bn₩24.07bn₩20.55bn₩21.03bn₩20.74bn₩23.59bn₩15.98bn
Operating income₩9.79bn₩8.70bn₩7.22bn₩6.77bn₩7.01bn₩7.78bn₩6.67bn₩5.08bn
Net income₩8.41bn₩8.62bn₩6.76bn₩6.86bn₩7.07bn₩7.14bn₩6.73bn₩4.34bn
Diluted earnings per share537.37551.37432.19438.54451.81456.28430.56277.20
Cash from operations₩9.96bn₩4.68bn₩8.90bn₩5.88bn₩5.21bn₩8.41bn₩18.63bn₩8.22bn
Capital spending−₩603.0m−₩168.0m−₩455.0m−₩446.0m−₩293.0m−₩225.0m−₩3.08bn−₩2.60bn
Free cash flow₩9.36bn₩4.51bn₩8.45bn₩5.43bn₩4.92bn₩8.19bn₩15.55bn₩5.62bn
Total assets₩226.23bn₩225.35bn₩217.81bn₩207.38bn₩196.92bn₩200.91bn₩192.44bn₩183.75bn
Cash and short-term investments—————₩134.72bn₩126.52bn₩115.33bn
Debt—————₩119.6m₩129.0m₩71.1m
Shareholders' equity₩201.02bn₩192.11bn₩195.36bn₩188.40bn₩181.62bn₩174.63bn₩176.88bn₩170.51bn

Financial ratios

Data as of 3 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin65.4%62.2%67.3%68.7%70.9%71.8%———
Operating margin21.8%20.7%26.0%25.2%25.5%26.8%———
Net margin21.0%19.4%23.9%20.0%20.1%22.2%———
Return on equity14.2%13.0%14.5%12.0%13.6%15.4%———
Return on assets12.8%12.0%13.1%11.0%12.4%13.6%———
Free cash flow yield——————14.2%11.2%6.9%
Revenue growth11.1%22.6%14.2%-3.3%7.7%-1.9%———
Earnings growth20.6%-0.6%36.3%-3.9%-2.3%-5.8%———
Current ratio8.40x10.12x7.94x9.99x9.39x7.63x———
Debt to equity———0.00x0.00x0.03x0.04x0.01x0.00x
Equity ratio89.7%91.9%90.2%91.5%90.9%88.5%———
Interest coverage729.87x604.47x1186.22x2423.68x582.98x388.54x———
R&D as a share of sales2.5%2.9%2.7%3.4%3.3%3.4%———
Buybacks as a share of market value——————-9.6%3.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.8%10.1%13.9%
Operating income10.3%5.6%20.3%
Net income17.8%8.9%23.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.9%65.6%67.2%69.2%
Operating margin21.3%23.1%24.0%24.3%
Net margin20.3%21.0%21.1%20.8%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings10.38.04.34.45.56.29.810.515.111.9
Price to sales2.21.61.00.91.11.42.32.43.22.2

Dividends and splits

Per share, in the currency the company pays

Paid for 19 years. Last went ex-dividend on 29 Dec 2025.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year750.00600.00375.00350.00350.00325.00375.00325.00
  • 2-for-1 split · 30 Oct 2024
  • 13-for-10 split · 12 Jun 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.